Mr. Tabora, senior scientific director of Bristol Myers Squibb, will deliver the fall 2024 Edward L. Paul lecture.
Event Actions
The UVA Department of Chemical Engineering is pleased to announce Mr. Tabora, senior scientific director of Bristol Myers Squibb, will present the annual Edward L. Paul Lecture on Pharmaceutical Development.
Two key objectives of pharmaceutical development are identifying the optimal routes, processes and conditions for medicine production, and establishing a robust control strategy to maintain product quality throughout the commercial manufacturing lifecycle. These objectives are often impeded by the inherent uncertainties in design decisions and the variability within the manufacturing environment, leading to a range of quality outcomes. Bayesian methodologies offer powerful tools to quantify these uncertainties and inform decision-making in process development. This talk will explore use cases, specifically within crystallization development, to illustrate these concepts.
The lecture will be held at 11 a.m. Thursday, September 26, in Harrison Small Auditorium at the Albert and Shirley Small Special Collections Library.
Mr. Tabora earned his Bachelor’s degree from Louisiana State University and his Ph.D. from the University of Virginia, both in Chemical Engineering. He began his career at Merck Research Laboratories before transitioning to Eli Lilly, eventually joining the Chemical Process Development team at Bristol Myers Squibb (BMS). With a focus on small molecule pharmaceutical development, Mr. Tabora has specialized in mathematical modeling and data visualization analysis. In addition to his industry work, he serves as an adjunct professor at Manhattan College and Stevens Institute of Technology.
Mr. Tabora is a fellow of the American Institute of Chemical Engineers and a member of the National Academy of Engineering.